• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-145 的表达恢复通过靶向 FSCN1 抑制前列腺癌细胞增殖、迁移和侵袭。

Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.

机构信息

Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

Int J Oncol. 2011 Apr;38(4):1093-101. doi: 10.3892/ijo.2011.919. Epub 2011 Jan 21.

DOI:10.3892/ijo.2011.919
PMID:21258769
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression, primarily at the post-transcriptional level. Growing evidence suggests that miRNAs function as oncogenes or tumor suppressors in human cancers. The down-regulation of miR-145 has been reported in many types of human cancer, including prostate cancer (PC), suggesting that miR-145 functions as a tumor suppressor. Using the PC cell lines, PC3 and DU145, gain-of-function assays revealed that miR-145 transfection inhibited cell proliferation, migration and invasion. Fascin homolog 1 (FSCN1), an actin-bundling protein, is a candidate target gene of miR-145 based on genome-wide gene expression analysis. A luciferase reporter assay showed a significantly decreased signal at two miR-145 target sites at the 3'UTR of FSCN1, suggesting that miR-145 directly regulates FSCN1. In FSCN1 loss-of-function assays, cell growth, migration and invasion were all inhibited, implying that FSCN1 is associated with the progression of PC. The identification of tumor suppressive miRNAs and their target genes could provide new insights into the potential mechanisms of prostate carcinogenesis.

摘要

微小 RNA(miRNAs)是一种小的非编码 RNA,主要在转录后水平调节基因表达。越来越多的证据表明,miRNAs 在人类癌症中作为癌基因或肿瘤抑制因子发挥作用。miR-145 的下调已在许多类型的人类癌症中报道,包括前列腺癌(PC),表明 miR-145 作为肿瘤抑制因子发挥作用。使用 PC 细胞系 PC3 和 DU145,功能获得实验表明,miR-145 转染抑制细胞增殖、迁移和侵袭。细丝蛋白 1(FSCN1),一种肌动蛋白成束蛋白,基于全基因组基因表达分析,是 miR-145 的候选靶基因。荧光素酶报告基因实验显示 FSCN1 的 3'UTR 上两个 miR-145 靶位点的信号显著降低,表明 miR-145 直接调节 FSCN1。在 FSCN1 功能丧失实验中,细胞生长、迁移和侵袭均受到抑制,表明 FSCN1 与 PC 的进展有关。肿瘤抑制 miRNAs 及其靶基因的鉴定可为前列腺癌发生的潜在机制提供新的见解。

相似文献

1
Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.miR-145 的表达恢复通过靶向 FSCN1 抑制前列腺癌细胞增殖、迁移和侵袭。
Int J Oncol. 2011 Apr;38(4):1093-101. doi: 10.3892/ijo.2011.919. Epub 2011 Jan 21.
2
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.miR-145、miR-133a 和 miR-133b:抑癌 miRNAs 在食管鳞癌细胞中靶向 FSCN1。
Int J Cancer. 2010 Dec 15;127(12):2804-14. doi: 10.1002/ijc.25284.
3
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.miR-145 过表达抑制转移性黑素瘤细胞的迁移和侵袭。
Int J Oncol. 2013 Apr;42(4):1443-51. doi: 10.3892/ijo.2013.1823. Epub 2013 Feb 12.
4
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
5
Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).谷胱甘肽 S-转移酶 P1 (GSTP1) 抑制头颈部鳞状细胞癌 (HNSCC) 中的细胞凋亡及其受 miR-133α 的调控。
Int J Mol Med. 2011 Mar;27(3):345-52. doi: 10.3892/ijmm.2010.589. Epub 2010 Dec 22.
6
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.miR-218 在染色体 4p15.31 的基因组缺失区域作为抑癌基因在膀胱癌中发挥作用。
Int J Oncol. 2011 Jul;39(1):13-21. doi: 10.3892/ijo.2011.1012. Epub 2011 Apr 20.
7
Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.肌动蛋白相关蛋白 2/3 复合物亚基 5(ARPC5)促进细胞迁移和侵袭,并且在头颈部鳞状细胞癌中受抑癌 microRNA-133a 的直接调控。
Int J Oncol. 2012 Jun;40(6):1770-8. doi: 10.3892/ijo.2012.1390. Epub 2012 Feb 29.
8
Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.长链非编码 RNA PCAT-1 通过 miR-145-5p 调控 FSCN1 促进前列腺癌的发生。
Biomed Pharmacother. 2017 Nov;95:1112-1118. doi: 10.1016/j.biopha.2017.09.019. Epub 2017 Oct 6.
9
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.前列腺癌细胞中雄激素受体靶向 microRNAs 的系统分析。
Cancer Res. 2011 Mar 1;71(5):1956-67. doi: 10.1158/0008-5472.CAN-10-2421. Epub 2011 Feb 22.
10
miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.miR-185 靶向 RhoA 和 Cdc42 的表达并抑制人结直肠细胞的增殖潜能。
Cancer Lett. 2011 Feb 28;301(2):151-60. doi: 10.1016/j.canlet.2010.11.009. Epub 2010 Dec 24.

引用本文的文献

1
MicroRNA-145 in urologic tumors: biological roles, regulatory networks, and clinical translation.泌尿系统肿瘤中的MicroRNA-145:生物学作用、调控网络及临床转化
Front Pharmacol. 2025 Jul 4;16:1609646. doi: 10.3389/fphar.2025.1609646. eCollection 2025.
2
FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing.FSCN1是通过单细胞和批量RNA测序揭示的动脉粥样硬化的潜在治疗靶点。
J Inflamm Res. 2024 Nov 25;17:9683-9696. doi: 10.2147/JIR.S480528. eCollection 2024.
3
Role of actin-binding proteins in prostate cancer.
肌动蛋白结合蛋白在前列腺癌中的作用。
Front Cell Dev Biol. 2024 Jul 11;12:1430386. doi: 10.3389/fcell.2024.1430386. eCollection 2024.
4
Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathway.MEG3的缺失通过NQO1/FSCN1途径促进了砷诱导致癌过程中迁移和侵袭能力的增强。
Am J Cancer Res. 2023 Jun 15;13(6):2307-2322. eCollection 2023.
5
miR-4482 and miR-3912 aim for 3'UTR of ERG mRNA in prostate cancer.miR-4482 和 miR-3912 靶向前列腺癌中 ERG mRNA 的 3'UTR。
PLoS One. 2023 Jun 13;18(6):e0286996. doi: 10.1371/journal.pone.0286996. eCollection 2023.
6
The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?Fascin-1 在人类泌尿系统癌症中的作用:有前途的生物标志物还是治疗靶点?
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231175733. doi: 10.1177/15330338231175733.
7
Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis.血浆 microRNAs 与转移性去势抵抗性前列腺癌患者治疗结局的相关性:一项基于医院的队列研究和计算机模拟分析。
Int J Mol Sci. 2023 May 22;24(10):9101. doi: 10.3390/ijms24109101.
8
Crosstalk between miRNAs and DNA Methylation in Cancer.miRNAs 与癌症中 DNA 甲基化的相互作用。
Genes (Basel). 2023 May 12;14(5):1075. doi: 10.3390/genes14051075.
9
Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer.微小RNA的差异表达导致非裔美国前列腺癌男性的肿瘤侵袭性和种族差异。
Cancers (Basel). 2023 Apr 17;15(8):2331. doi: 10.3390/cancers15082331.
10
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?前列腺癌转录组学的年龄差异:老年男性的原发肿瘤是否存在固有差异?
Cancer Prev Res (Phila). 2022 Dec 1;15(12):815-825. doi: 10.1158/1940-6207.CAPR-22-0212.